Who invested in Telomere Therapeutics?
Telomere Therapeutics's investors include Vivo Capital.

Funding summaryUpdated 26 Oct 2026
$2.3Mraised across 1 round since 2021, from 1 source
Telomere Therapeutics's investors include Vivo Capital.
Telomere Therapeutics has raised $2.3M across 1 round since 2021.
Telomere Therapeutics's most recent round was a Seed of $2.3M in May 2021.
Its most recent round, $2.3M in May 2021, is also its largest on record.
Telomere Therapeutics's first round on record, in May 2021, was backed by Vivo Capital.
Telomere Therapeutics's latest named round is a Seed, in May 2021.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.